Criyoglobulins are immunoglobulins that precipitate at low temperatures and dissolve at higher temperatures. The existence of cryoglobulins in serum is termed cryoglobulinaemia. Although, the patients with cryoglobulinaemia or cryoglobulinemic vasculitis, the consequence of cryoglobulinaemia, have typical symptoms related to the presence of cryoglobulins, may patients with cryoglobulinaemia remain asymptomatic. Criyoglobulinaemia a systemic vasculitis involving primarily small vessels, can be associated with infections, lymphoproliferative malignancies or autoimmune diseases. Type 1 criyoglobulins can be found in patients with , lymphoproliferative disorders, such as Waldernström macroglobulinaemia or multiple myelom, while mixt criyoglobulins are detected in patients with autoimmune diseases, lymphoproliferative disorders or infections, most commonly hepatitis C virus. We present a 38-year-old man with criyoglobulinemic vasculitis secondary to multiple myeloma. The patient was admitted to hospital with one year history of cutaneous purpura, aggrevated with cold, on his legs and ears accompanied by arthralgia. Skin biopsy revealed leukocytoclastic vasculitis. There was serum cryoglobulinaemia and serum immunofixation electropheresis showed a IgG kapa monoclonal gamapathy. Contrasted computed tomography evidenced osteolytic lesions on his 4th rip, biopsy of which demonstrated a plasmocytoma. The bone marrow biopsy yielded 90 % of kapa monoclonal plasma cells verifying the diagnosis of multiple myeloma.
INTRODUCTION
A case of cryoglobulinemic vasculitis secondery to multiple myeloma was reported, characterized by cutaneous purpura, aggrevated by cold, and leucocytoclastic vasculitis along with blood positivity to monoclonal IgG cryoglobulin and features of multiple myeloma. This report illustrates the importance of considering underlying diseases in any patient with cryoglobulinemic vasculitis. verifying the diagnosis of multiple myeloma (Fig 5a, b) . Based on the clinical and histological findings and the presence of monoclonal IgG cryoglobulin in serum, a diagnosis of cryoglobulinemic vasculitis secondery to multiple myeloma was made, and the patient was discharged to the hematology clinic.
CASE REPORT

DISCUSSION
Cryoglobulins are immunoglobulins that precipitate as serum is cooled below core body temperatures (1) . Criyoglobulinemia, the existence of cryoglobulins in serum, is an immune complex-mediated systemic vasculitis involving mostly small, but sometimes larger vessels, and can be associated with infections, autoimmune disorders, and malignancies. The most common cause is infection with hepatitis C virus (2) (3) (4) (5) . Cryoglobulinemic vasculitis is the consequence of cryoglobulinemia(3). The patients with cryoglobulinemia or cryoglobulinemic vasculitis have symptoms related to the presence of cryoglobulins. The percentage of patients who develop symptoms varies from 2% to 50% (6) . Purpura, arthralgia, weakness, peripheral neuropathy, and acute nephritic or nephrotic syndrome are commonly seen in cryoglobulinemic vasculitis (2) (3) (4) (5) . The development of cryoglobulinemic symptoms is affected by age, underlying illness, and the characteristiesof the cryoglobulins (6). Type 1 cryoglobulins can be found in patients with lymphoproliferative disorders, such as Waldenström's macroglobulinemia or multiple myeloma, while mixed cryoglobulins are detected in patients with autoimmune disorders, lymphoproliferative disorders or chronic infections. When no underlying disease is present, this is called essential or idiopathic cryoglobulinemia (1) .
Cutaneous purpura is the most characteristic manifestation of cryoglobulinemic vasculitis (6) , and serum complement factor 4 levels are usually low or below detection (7) .
Cryoglobulinemic vasculitis should be diagnosed in the presence of clinical signs of the vasculitis and cryoglobulinemia, and histologic proof of an immune complex-mediated vasculitis.
We report a man with cryoglobulinemic vasculitis due to multiple myeloma. Our case illustrates the importance of identifying the presence of underlying diseases in any patient with cryoglobulinemic vasculitis so that treatment can be optimized to treat the vasculitic process.
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